arrow
H

Heiner Wedemeyer

Hannover Medical School
H指数:104
被引数:5.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic Dysfunction-Associated Steatotic Disease and Genetic Risk in Germany—An Observational Real-World Cohort Study

代谢功能障碍相关脂肪性病变与遗传风险在德国——一项观察性真实世界队列研究

2026-10-080
OAAI
Intestinal fatty acid-binding protein (I-FABP) at ICU admission as early biomarker of intestinal injury and predictor of mortality in septic shock

ICU入组时肠道脂肪酸结合蛋白(I-FABP)作为肠道损伤的早期生物标志物及感染性休克患者死亡率的预测因子

2026-08-260
OA
Complementary use of autoantibody detection methods facilitates diagnosis of juvenile autoimmune hepatitis and autoimmune sclerosing cholangitis

多种自身抗体检测方法的互补应用有助于诊断青少年自身免疫性肝炎和自身免疫性硬化性胆管炎

2025-12-060
OAAI
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy

Hepatitis D (HIDIT-II)研究:聚乙二醇干扰素联合替诺福韦治疗96周后的十年随访——联合疗法改善临床结局

2025-11-010
OAAI
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D

处理感知和语言障碍对每日皮下注射Bulevirtide治疗丁型肝炎病毒学反应的影响

2025-10-180
OAAI
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D☆

布勒韦尔肽的治疗反应与慢性丁型肝炎患者门静脉高压的改善相关。

2025-10-170
OAAI
Transient tissue residency and lymphatic egress define human CD56bright NK cell homeostasis

短暂的组织驻留和淋巴流出定义了人类CD56bright NK细胞的稳态

2025-10-140
OAAI